Tonomy

Company Overview

Snapshot

Founded in November 2017 by Gil Shamai and Niv Narkiss, Tonomy operated with 1-10 employees. The company secured funding across one round from Israel Innovation Authority and MindUP. Tonomy ceased operations in April 2024.

Business overview

Tonomy developed a non-contact home tonometer and an accompanying app designed to enable individuals to measure their intra-ocular pressure (IOP) at home. This solution aimed to reduce the risk and improve the management of glaucoma by providing users with diagnostic data to share with their physicians for treatment and medication. The company's proprietary tonometer technology focused on automatic and autonomous IOP testing, serving the Health Tech & Life Sciences sector, particularly in digital healthcare, medical devices, and patient remote monitoring.

Strategic signal

Tonomy ceased operations in April 2024. This indicates a complete halt in the company's development and commercialization efforts for its home tonometer and app, signaling to investors and innovation teams that the venture is no longer active in the Health Tech & Life Sciences market.

Company Intelligence Q&A

What is Tonomy's primary offering?

Tonomy developed a non-contact home tonometer and an app to allow individuals to measure their intra-ocular pressure (IOP) at home, aiming to reduce the risk and improve the management of glaucoma.

When was Tonomy founded and by whom?

Tonomy was founded in November 2017 by co-founders Gil Shamai and Niv Narkiss.

What is the current operational status of Tonomy?

Tonomy is currently non-active, having ceased to operate in April 2024.

Which investors participated in Tonomy's funding round?

In December 2017, Tonomy received funding from Israel Innovation Authority and MindUP.

What markets did Tonomy aim to serve?

Tonomy aimed to serve the global market within the Health Tech & Life Sciences sector, specifically targeting patients and healthcare providers with its diagnostic and remote monitoring solutions.